DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/2npbs6/motor_neurone) has announced the addition of the "Motor Neurone Diseases-Pipeline Insights, 2016" report to their offering.
Motor Neurone Diseases-Pipeline Insights, 2016 provides in depth insights on the pipeline drugs and their development activities around the Motor Neurone Diseases. The report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration.
Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details.
The report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Motor Neurone Diseases.
The report also assesses the Motor Neurone Diseases therapeutics by Monotherapy, Combination products, molecule type and Route of Administration.
- The report provides competitive pipeline landscape of Motor Neurone Diseases
- The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
- Coverage of the Motor Neurone Diseases pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
- The report reviews key players involved in the therapeutics development for Motor Neurone Diseases and also provide company profiling
- The report also gives the information of dormant and discontinued pipeline projects
- Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type
Key Topics Covered:
- Motor Neurone Diseases Overview
- Motor Neurone Diseases Pipeline Therapeutics
- Motor Neurone Diseases Therapeutics under Development by Companies
- Motor Neurone Diseases Filed and Phase III Products
- Comparative Analysis
- Motor Neurone Diseases Phase II Products
- Motor Neurone Diseases Phase I and IND Filed Products
- Motor Neurone Diseases Discovery and Pre-Clinical Stage Products
- Motor Neurone Diseases - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Motor Neurone Diseases - Discontinued Products
- Motor Neurone Diseases - Dormant Products
- Companies Involved in Therapeutics Development for Motor Neurone Diseases
For more information visit http://www.researchandmarkets.com/research/2npbs6/motor_neurone